Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to monitor and mitigate the impact of antimicrobial resistance on marginalised communities in the UK, including (1) people of migrant, refugee or asylum seeker status, (2) prisoners, and (3) homeless people.

The UK Health Security Agency’s antimicrobial resistance (AMR) programme is committed to tackling and reducing antimicrobial health inequalities nationwide. Over the years, the AMR health inequalities workstream has taken a systematic approach to increasing our work to understand and address health inequalities in relation to AMR. This involves improving our understanding of the association between health inequalities and antimicrobial usage and resistance; developing a health inequalities and AMR engagement strategy including learning from the wider public health community; and producing recommendations for public health action.

Future projects include surveying knowledge, attitudes, and health-seeking behaviours towards antibiotics in different populations, identifying and improving surveillance reporting gaps required to understand the impact of AMR and AMR-targeted interventions on Core20PLUS populations, and publishing the health inequalities scoping review. The Core20PLUS populations include vulnerable migrants, people in contact with the justice system and people experiencing homelessness.

Furthermore, antibiotic consumption data within prisons, which is grouped with “other community settings”, are monitored and published annually within the antimicrobial consumption chapter of the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report.